When METTL14 was inhibited, m6A levels decreased significantly (P < 0.05, Figure 4A and 4B), suggesting the role of METTL14 in modulating m6A methylation in NAFLD. This evidence concerns the gene METTL14 and metabolic dysfunction-associated steatotic liver disease.